Eric Mortenson
About Eric Mortenson
Company
Eric Mortenson is currently employed at Bristol-Myers Squibb as a Senior Field Medical Scientist. Bristol-Myers Squibb, located in New Jersey, United States, is where he has built a substantial part of his career in the medical field. This pharmaceutical giant focuses on discovering, developing, and delivering innovative medicines that help patients prevail over serious diseases.
Title
Eric Mortenson holds the title of Senior Field Medical Scientist. His role involves leveraging his extensive knowledge in medical science to support healthcare professionals, provide medical insights, and contribute to the strategic direction of medical products and treatments. He has been serving in this position since October 2016.
Education and Expertise
Eric Mortenson's educational background includes a Doctorate in Immunology, achieved from the University of Chicago, where he studied from 2006 to 2012. Additionally, he holds a Bachelor of Science in Biology from Westmont College, obtained between 1996 and 2000. His expertise encompasses over 9 years in tumor immunology and immunotherapy, specializing in both solid and hematologic malignancies. His academic and professional experiences span innovation in immunology and oncology.
Professional Background
Prior to his current role, Eric Mortenson served as a Medical Science Liaison - Oncology at Bristol-Myers Squibb from 2014 to 2016. His previous experience includes a postdoctoral fellowship at MD Anderson Cancer Center's Department of Melanoma Medical Oncology from 2013 to 2014. He spent six years as a Graduate Research Associate at the University of Chicago, focusing on immunology. Earlier in his career, Mortenson was a Research Technician in the Vaccine Research Group at Mayo Clinic from 2004 to 2006.
Career Achievements
Eric Mortenson has a demonstrated ability to drive innovation and make meaningful connections in both academic and industry settings. Additionally, he co-founded Bellevue Healthcare, where he worked from 2000 to 2003 in Redmond, Washington. His career spans various roles that have collectively contributed to advancing the understanding and treatment of immunological diseases, particularly in oncology.